NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 2026-11-04 17:39இன்று 0 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
Advance Agrolife Q2 FY27 Revenue Up 35% YoY to ₹287.2 Cr; PAT Drops 25.7% to ₹11.8 Cr
Advance Agrolife reported a 35.0% YoY rise in Q2 FY27 revenue to ₹287.15 Cr (₹2,871.5 mn), but Q2 PAT contracted 25.7% YoY to ₹11.79 Cr (₹117.9 mn) due to margin pressures. EBITDA margin for Q2 contracted by 4.52 percentage points to 7.6% (from 12.12% in Q2 FY26). For H1 FY27, revenue surged 62.0% YoY to ₹617.56 Cr while PAT expanded 38.4% YoY to ₹34.34 Cr. The company is doubling its export reach to 14 countries and plans to commission its fourth plant at Gidhani by Q4 FY27.
உச்சம் நம்பிக்கை
என்ன மாறியதுAdvance Agrolife reported mixed Q2 FY27 results, showing strong top-line momentum driven by domestic and export expansion, offset by significant EBITDA margin dilution.
ஏன் இது முக்கியம்Top-line growth remains robust across formulations and B2B channels, but quarterly margin degradation highlights pricing pressure and rising cost challenges in the agrochemical market.
📅 குறுகிய காலம்Market reaction may be muted or cautious as strong revenue growth is overshadowed by a 25.7% drop in Q2 net profit and margin compression.
📈 நீண்ட காலம்Portfolio diversification with 500+ CIB & RC registrations, expansion from 7 to 14 export countries, and the Gidhani plant rollout provide structural volume growth drivers.
⚠ அபாய எச்சரிக்கைகள்
Sharp margin contraction (EBITDA margin down 4.52 percentage points YoY in Q2)
Customer concentration risk (top 10 customers contributed 54% of revenue in FY24)
Vulnerability to competitive pricing pressure and commodity input swings
👀 கவனிக்க வேண்டியவை
Track whether margin compression reverses in Q3 and monitor the operational commissioning timeline of the new Gidhani plant in Q4 FY27.
96% YoY Revenue Growth in Q1 FY27; New Technical Units to Drive Backward Integration
Advance Agrolife reported a robust Q1 FY27 with revenue reaching ₹330.4 cr, which is approximately 98% of its total FY26 revenue (₹336.5 cr). PAT surged 152% YoY to ₹22.54 cr, driven by a strategic shift from being a pure formulator to an integrated technical manufacturer. The company is aggressively expanding capacity, with Unit-4 expected to start in Q3 FY27 and construction already underway for Unit-5 in Dahej, Gujarat. Management aims to significantly de-risk the business by increasing export revenue share from 2% to 20% by FY29.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company has successfully transitioned from a trading/formulation model to an integrated technical manufacturer, resulting in a massive volume and margin jump in Q1 FY27.
ஏன் இது முக்கியம்Backward integration into technical grade pesticides allows the company to capture 'molecule margins' previously lost to external suppliers and reduces logistics costs through captive consumption.
📅 குறுகிய காலம்The stock is likely to react positively to the exceptional Q1 results where quarterly revenue nearly equaled the previous full year's performance.
📈 நீண்ட காலம்The structural shift toward technical manufacturing and the expansion into the Dahej chemical belt provide a clear path for scaling beyond ₹600 cr revenue, provided execution on new units remains on track.
👀 கவனிக்க வேண்டியவை
Investors should monitor the timely commissioning of Unit-4 in Q3 FY27 and the progress of the Dahej facility (Unit-5), as these are critical for the company's margin-expansion strategy through backward integration.
152% PAT Growth: Advance Agrolife Q1 Revenue hits ₹330.4 Cr, nearly matching FY26 total
Advance Agrolife reported its highest-ever quarterly performance for Q1 FY27, with revenue surging 96% YoY to ₹330.4 Cr. Remarkably, this single quarter's revenue represents approximately 98% of the company's total revenue for the entire previous financial year (FY26: ₹336.5 Cr). Net profit grew by 152% YoY to ₹22.55 Cr, driven by improved EBITDA margins of 10.6%. The company is also progressing on capacity expansions, with Unit-4 expected to start in Q3 FY27 and construction beginning for Unit-5 in Dahej.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company achieved a massive scale-up in operations, with Q1 FY27 revenue nearly matching the total revenue generated in all of FY26.
ஏன் இது முக்கியம்This indicates a successful deployment of IPO proceeds for working capital and a significant expansion in market share within the B2B agrochemical segment, supported by upcoming technical manufacturing capacity.
Q1 FY27 Revenue: ₹330.4 கோடிQ1 Revenue vs FY26 Total Revenue: 98.18%PAT Growth (YoY): 152%EBITDA லாப வரம்பு: 10.6%Unit-5 Land Area: 17,734.54 sq. mtrs
📅 குறுகிய காலம்The stock is likely to react positively to the significant earnings beat and the fact that quarterly revenue has reached annual-level scales.
📈 நீண்ட காலம்Structural growth is supported by the transition to technical manufacturing (Unit-4 and Unit-5) which typically offers better margins than formulations, and a target to scale beyond ₹600 Cr revenue.
⚠ அபாய எச்சரிக்கைகள்
High client concentration (top 10 customers contribute 54% of revenue)
Vulnerability to monsoon cycles
Highly competitive industry with limited pricing power
👀 கவனிக்க வேண்டியவை
Investors should monitor the execution timeline for Unit-4 in Q3 FY27 and the sustainability of these high volumes, as Q1 revenue almost equaled the previous full year's performance.
Q1 Revenue Grows 96% YoY to ₹330.40 Cr; Net Profit Jumps 152%
Advance Agrolife reported a robust performance for Q1 FY27, with revenue from operations nearly doubling to ₹330.40 cr from ₹168.61 cr in Q1 FY26. Net profit surged 152% YoY to ₹22.55 cr, driven by higher scale and improved operational leverage. The board also strengthened its leadership by appointing Brijmohan Sharma, a banking veteran with 40 years of experience, as an Independent Director. These results indicate strong momentum toward the company's stated goal of scaling revenue beyond ₹600 cr annually.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe company reported a significant YoY growth in both top-line and bottom-line for the first quarter of FY27 and added a banking veteran to its board.
ஏன் இது முக்கியம்The sharp increase in revenue suggests successful execution of the company's B2B expansion strategy and better market penetration, moving it closer to its ₹600 cr+ annual revenue target.
Q1 FY27 Revenue: ₹330.40 கோடிQ1 FY27 Net Profit: ₹22.55 கோடிYoY Revenue Growth: 96%YoY Net Profit Growth: 152%EBITDA லாப வரம்பு: 10.68%
📅 குறுகிய காலம்The stock is likely to react positively to the strong earnings growth and margin expansion reported for the June quarter.
📈 நீண்ட காலம்If the company maintains this growth trajectory, it could significantly re-rate; however, long-term risks include high client concentration and regulatory shifts in pesticide molecules.
⚠ அபாய எச்சரிக்கைகள்
Seasonal dependency on monsoons
High customer concentration (top 10 clients contribute 54% of revenue)
Raw material price volatility
👀 கவனிக்க வேண்டியவை
Investors should monitor the sustainability of these margins in Q2 and Q3, which are typically influenced by monsoon patterns and cropping cycles in the agrochemical sector.
Advance Agrolife FY26 Revenue Surges to ₹6,369 Mn; Targets 20% Export Share by FY29
Advance Agrolife Limited (AAL) reported a robust performance for FY26, with total income nearly doubling to ₹6,369 million from ₹3,528 million in FY25. The company is executing a strategic pivot from a pure-play formulator to an integrated technical manufacturer, which is expected to reduce COGS by 25-30% for specific products. A major growth catalyst is the 4x capacity expansion of 2,4-D herbicides to 10,000 MT and a target to increase export revenue from 2% to 20% by FY29. With 410+ CIB & RC registrations, AAL maintains a strong regulatory moat with high switching costs for its B2B clientele.
முக்கிய அம்சங்கள்
Total income for FY26 grew to ₹6,369 million, a significant increase from ₹3,528 million in the previous fiscal year.Q4 FY26 EBITDA margin stood at 12.7% with a PAT of ₹74.6 million, reflecting improved operational efficiency.Executing a 4x capacity expansion in 2,4-D herbicides to reach 10,000 MT, targeting domestic supply deficits.Strategic goal to scale export revenue share from the current 2% to 20% by FY29, targeting markets like LATAM and Brazil.Backward integration into technical manufacturing via Unit I and Unit IV aims to capture higher molecular margins.
👀 கவனிக்க வேண்டியவை
Investors should focus on the timely commissioning of the Unit IV technical plant and the ramp-up of the 2,4-D capacity as primary growth drivers. The company's transition to an integrated player and its export expansion strategy are key catalysts for long-term margin improvement.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
Advance Agrolife Q4 PAT Surges 422% YoY to ₹74.6 Million; FY26 Revenue Up 28%
Advance Agrolife reported a stellar performance for Q4 FY26, with PAT growing 422% YoY to ₹74.61 million and revenue increasing 40% to ₹1259.07 million. For the full year FY26, the company achieved a 28% revenue growth and a 38% increase in PAT, reaching ₹352.84 million. Operational efficiency improved significantly, with Q4 EBITDA margins expanding by 425 bps to 10.8%. The company is aggressively expanding its capacity with a new facility in Gidani expected by Q2 FY27 and land acquisition for another unit in Dahej.
முக்கிய அம்சங்கள்
Q4 FY26 PAT jumped 422% YoY to ₹74.61 million, while annual PAT rose 38% to ₹352.84 million.Revenue for Q4 FY26 grew 40% YoY to ₹1259.07 million, contributing to a full-year revenue of ₹6417.5 million.EBITDA margins for Q4 saw a massive expansion of 425 bps YoY, reaching 10.8%.CARE Ratings upgraded the company's long-term bank facilities from BBB to BBB+.Planned capex of ₹250 million for Unit-4 and land acquisition for Unit-5 in Dahej signal strong future growth.
👀 கவனிக்க வேண்டியவை
The strong earnings growth and margin expansion, coupled with aggressive expansion plans and a credit rating upgrade, provide a positive outlook. Investors should monitor the timely execution of the Unit-4 facility and the impact of backward integration on future margins.
Advance Agrolife Reports Zero Deviation in Utilization of ₹1,928.42 Million IPO Proceeds
Advance Agrolife Limited has confirmed that there were no deviations or variations in the utilization of funds raised through its Initial Public Offer (IPO) for the quarter ended March 31, 2026. The company raised ₹1,928.42 million via a fresh issue in October 2025. The monitoring agency, Care Ratings Limited, and the company's Audit Committee have reviewed the fund utilization and reported no adverse findings. This compliance filing demonstrates management's adherence to the objects of the issue as stated in the prospectus.
முக்கிய அம்சங்கள்
Raised ₹1,928.42 million through a fresh issue in its IPO on October 06, 2025.Confirmed zero deviation or variation in the use of funds for the quarter ended March 31, 2026.Care Ratings Limited is the appointed monitoring agency for the fund utilization.The Audit Committee and auditors provided no negative comments on the fund deployment.The company has been listed on BSE and NSE since October 08, 2025.
👀 கவனிக்க வேண்டியவை
Investors should take this as a positive sign of corporate governance and transparency. No immediate action is required, but shareholders should continue to monitor how the deployed capital impacts future earnings growth.
Advance Agrolife Approves FY26 Audited Results and Re-appoints Auditors for FY 2026-27
Advance Agrolife Limited's Board of Directors approved the audited standalone financial results for the quarter and fiscal year ended March 31, 2026. The statutory auditors issued an unmodified opinion, suggesting the financial reports are presented fairly in all material respects. Additionally, the company re-appointed M/s. PSAG & Associates as Internal Auditors and M/s M Goyal & Co as Cost Auditors for the 2026-27 period. These administrative steps ensure continued regulatory compliance and internal oversight for the upcoming fiscal year.
முக்கிய அம்சங்கள்
Approved audited standalone financial results for the quarter and year ended March 31, 2026.Statutory auditors provided an unmodified opinion on the financial statements.Re-appointed M/s. PSAG & Associates as Internal Auditors for the financial year 2026-27.Re-appointed M/s M Goyal & Co as Cost Auditors for the financial year 2026-27.
👀 கவனிக்க வேண்டியவை
Investors should analyze the full financial report for specific growth metrics and margin performance once the detailed tables are released. The unmodified audit opinion is a positive sign of financial transparency and reporting integrity.
Advance Agrolife FY26 Net Profit Surges 37.6% to ₹352.8M; Revenue Up 27%
Advance Agrolife reported a strong financial performance for the year ended March 31, 2026, with annual revenue from operations growing 27% to ₹6,377.75 million. Net profit for the full year increased significantly by 37.6% to ₹352.84 million compared to ₹256.38 million in the previous year. The fourth quarter (Q4 FY26) showed exceptional growth, with PAT rising to ₹74.61 million from ₹14.28 million in the same quarter last year. Additionally, the board approved the re-appointment of internal and cost auditors for the 2026-27 fiscal year.
முக்கிய அம்சங்கள்
Annual Revenue from Operations grew by 27% YoY to ₹6,377.75 million in FY26Full-year Net Profit (PAT) increased by 37.6% to ₹352.84 millionQ4 FY26 PAT saw a massive jump to ₹74.61 million compared to ₹14.28 million in Q4 FY25Annual Earnings Per Share (EPS) improved to ₹6.50 from ₹5.70 in the previous fiscalTotal Comprehensive Income for FY26 stood at ₹352.32 million
👀 கவனிக்க வேண்டியவை
Investors should view the strong bottom-line growth and significant margin improvement in Q4 as a positive sign of operational efficiency. The stock warrants a positive outlook, though investors should remain mindful of the seasonal nature of the agro-business.
Advance Agrolife Bags ₹30.38 Crore Order from National Fertilizers Limited (NFL)
Advance Agrolife Limited has secured a significant domestic order from National Fertilizers Limited (NFL) for the supply of various agrochemicals. The contract is valued at approximately ₹30.38 Crores and is expected to be executed by September 30, 2026. This order from a major Public Sector Undertaking (PSU) provides strong revenue visibility for the company in the upcoming quarters. The payment terms are structured at 90 days from the date of invoice, with a 5% security deposit requirement.
முக்கிய அம்சங்கள்
Total contract value is ₹30,37,91,000 (approx. ₹30.38 Crores)Order received from National Fertilizers Limited (NFL) for agrochemical supplyExecution timeline is short-term, with completion by September 30, 2026Payment terms are 90 days from the date of invoiceCompany is required to maintain a security deposit of 5% of the contract value
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development that enhances revenue visibility and validates the company's standing in the agrochemical sector. Monitor the company's quarterly results for execution progress and margin performance on this specific contract.
Advance Agrolife Credit Rating Upgraded to CARE BBB+; Stable for Rs 100.89 Cr Facilities
CARE Ratings has upgraded Advance Agrolife's long-term bank facilities from CARE BBB to CARE BBB+ with a stable outlook, signaling improved creditworthiness. The upgrade applies to long-term facilities totaling Rs 100.89 crore, which were enhanced from the previous Rs 92.09 crore. Additionally, the agency assigned new ratings for long/short-term facilities of Rs 6.00 crore and reaffirmed short-term ratings at CARE A3+. This positive revision is based on the company's audited FY25 and unaudited 9MFY26 financial performance.
முக்கிய அம்சங்கள்
Long-term bank facilities of Rs 100.89 crore upgraded to CARE BBB+; Stable from CARE BBB; StableTotal bank facilities rated by CARE Ratings amount to Rs 113.09 croreAssigned new ratings of CARE BBB+; Stable / CARE A3+ for Rs 6.00 crore long/short-term facilitiesReaffirmed CARE A3+ rating for short-term bank facilities worth Rs 6.00 croreUpgrade driven by operational and financial performance improvements in FY25 and 9MFY26
👀 கவனிக்க வேண்டியவை
The credit rating upgrade is a positive indicator of the company's strengthening balance sheet and may lead to lower borrowing costs. Investors should view this as a sign of reduced financial risk and improved operational stability.
Advance Agrolife to Invest ₹25 Cr for Capacity Expansion in Pretilachlor and PEDA
Advance Agrolife Limited is expanding its manufacturing capabilities at its Jaipur facility by adding production capacity for Pretilachlor Technical and its intermediate, PEDA. The company plans to add 5,000 MT p.a. of Pretilachlor and 3,700 MT p.a. of PEDA capacity within FY 2025-26. This expansion involves a total investment of approximately ₹25 crore, funded through a mix of term loans and internal accruals. The move is strategically aimed at strengthening backward integration following the imposition of anti-dumping duties by the Government of India.
முக்கிய அம்சங்கள்
Proposed capacity addition of 5,000 MT p.a. for Pretilachlor and 3,700 MT p.a. for PEDATotal estimated investment of ₹25 crore (₹18 cr for PEDA and ₹7 cr for Pretilachlor)Project completion targeted within the current financial year (FY 2025-26)Strategic backward integration to mitigate impact of anti-dumping duties on raw materialsFunding to be sourced via a combination of term loans and internal accruals
👀 கவனிக்க வேண்டியவை
Investors should monitor the timely execution of this capacity addition and its subsequent impact on operating margins due to improved backward integration. The proactive move to counter anti-dumping duties suggests management is focused on supply chain resilience.
Advance Agrolife to Acquire 17,491 Sq Mtrs Land in Gujarat for New Pesticide Plant
Advance Agrolife Limited has signed a Memorandum of Understanding (MOU) with Bileshwar Pharmaceuticals Pvt. Ltd. to acquire 17,491.02 square meters of land. The land is located in the Dahej-II GIDC Industrial estate in Bharuch, Gujarat, a major chemical hub. This acquisition is intended for setting up a new manufacturing facility for technical grade pesticides. This move signals a significant step towards expanding the company's production capacity and industrial footprint.
முக்கிய அம்சங்கள்
MOU signed on February 25, 2026, for the acquisition of 17,491.02 Sq Mtrs of land.New manufacturing plant to be established at Dahej-II GIDC Industrial estate, Gujarat.The facility will focus on the production of technical grade pesticides.Future updates regarding commercial operation dates and project details are expected in due course.
👀 கவனிக்க வேண்டியவை
This is a positive long-term growth indicator; investors should monitor the company's upcoming disclosures regarding CAPEX and project timelines. Watch for the impact on production capacity once the plant becomes operational.
Advance Agrolife Limited (AAL) reported a strong financial performance for 9M FY26, with total income rising 25% YoY to ₹5,153.9 million and PAT increasing 15% to ₹278.2 million. The company is executing a strategic pivot from a pure-play formulator to an integrated technical manufacturer to capture higher margins through backward integration. A major 4x capacity expansion for 2,4-D herbicides is underway, targeting 10,000 MT by Q4 FY28. Additionally, AAL aims to aggressively scale its export revenue share from the current 2% to 20% by FY29.
முக்கிய அம்சங்கள்
9M FY26 Total Income grew 25% YoY to ₹5,153.9 million, while EBITDA rose 20% to ₹502.5 million.Executing a 4x capacity expansion in 2,4-D herbicides to reach 10,000 MT, addressing domestic supply deficits.Strategic shift to backward integration in Technicals targeting a 25-30% reduction in COGS for specific products.Export revenue target set at 20% by FY29, up from the current 2%, focusing on regulated markets like LATAM and SE Asia.Maintains a robust intangible asset base with 410+ CIB & RC registrations, creating high entry barriers.
👀 கவனிக்க வேண்டியவை
Investors should focus on the company's transition from a formulator to a technical manufacturer, as this backward integration is expected to drive significant margin expansion. Monitor the timely execution of the Unit IV expansion and the ramp-up in export registrations as key growth catalysts.
Advance Agrolife Q3 FY26 Revenue Up 18% to ₹1,338M; 9M PAT Grows 15% to ₹278.2M
Advance Agrolife reported a steady performance for Q3 FY26 with revenue growing 18% YoY to ₹1,338 million, driven by increased demand and new B2B customer additions. For the nine-month period (9M FY26), revenue surged 25% to ₹5,153.9 million, while PAT increased by 15% to ₹278.2 million. The company is aggressively expanding its footprint with a new Unit-4 manufacturing facility in Rajasthan expected by Q2 FY27, backed by a ₹250 million capital expenditure. While margins saw a slight compression of 10-30 bps, the company is focusing on backward integration and export registrations to drive future growth.
முக்கிய அம்சங்கள்
9M FY26 Revenue grew by 25% YoY to ₹5,153.9 million compared to ₹4,127.8 million in 9M FY25.Q3 FY26 EBITDA increased 16% YoY to ₹73.5 million, though EBITDA margins slightly dipped to 5.5%.Planned ₹250 million capex for a new Unit-4 technical manufacturing facility at Gidani, expected by Q2 FY27.Setting up a 3.75 MW solar power plant and a new R&D laboratory to enhance operational efficiency and product pipeline.9M FY26 PAT rose 15% YoY to ₹278.2 million, although diluted EPS for Q3 fell to ₹0.47 from ₹0.62 due to equity dilution.
👀 கவனிக்க வேண்டியவை
Investors should monitor the timely execution of the Unit-4 facility and the impact of backward integration on margins. The stock remains a growth play in the agri-input space given its aggressive expansion and increasing B2B customer base.
Advance Agrolife Approves Q3 Results and 3.75 MW Solar Plant for Captive Consumption
Advance Agrolife Limited has approved its unaudited standalone financial results for the quarter and nine months ended December 31, 2025. In a strategic move to reduce operational costs, the board proposed the installation of a 3.75 MW solar power plant in Jodhpur, Rajasthan, for captive consumption. The project is currently awaiting necessary approvals from the Rajasthan Renewable Energy Corporation Limited (RRECL). Furthermore, the company has updated its internal code for fair disclosure of price-sensitive information to comply with SEBI norms.
முக்கிய அம்சங்கள்
Approved unaudited standalone financial results for the quarter and nine months ended December 31, 2025.Proposed installation of a 3.75 MW solar power plant in Jodhpur, Rajasthan.The solar project is designed for captive consumption to lower energy expenses.Updated the Code of Practices and Procedures for Fair Disclosure of UPSI.Project implementation is subject to RRECL and other regulatory clearances.
👀 கவனிக்க வேண்டியவை
Investors should review the detailed Q3 financial performance and monitor the timeline for the solar plant's commissioning. The move towards renewable energy for captive use is a positive step for long-term margin sustainability.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
